Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Monreal

Showing results (361-370 of 388) with videos related to

Pageof 39
Sort By:
Journal of the American College of Cardiology|October 1, 2025
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future DirectionsSina Rashedi, Hannah Leyva, Nada Hamade, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized TrialsAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of the American College of Cardiology|October 15, 2021
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art ReviewAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Thrombosis and Haemostasis|February 22, 2023
Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ StudyBehnood Bikdeli, Ying-Chih Lo, Candrika D Khairani, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
JAMA Cardiology|October 19, 2022
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical TrialParham Sadeghipour, Yaser Jenab, Jamal Moosavi, et al.
Thrombosis and Haemostasis|August 15, 2015
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer studyNick van Es, Marcello Di Nisio, Suzanne M Bleker, et al.
JAMA|October 5, 2021
Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical TrialDavid Jiménez, Alvar Agustí, Eva Tabernero, et al.
Thrombosis Research|June 1, 2023
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS studyRemedios Otero, José Luis Lobo, Raquel López, et al.
JAMA Cardiology|June 1, 2022
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A ReviewBehnood Bikdeli, Farbod Zahedi Tajrishi, Parham Sadeghipour, et al.
Pageof 39

Showing results (361-370 of 388) with videos related to

Sort By:
Pageof 39
Journal of the American College of Cardiology|October 1, 2025
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future DirectionsSina Rashedi, Hannah Leyva, Nada Hamade, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized TrialsAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of the American College of Cardiology|October 15, 2021
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art ReviewAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Thrombosis and Haemostasis|February 22, 2023
Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ StudyBehnood Bikdeli, Ying-Chih Lo, Candrika D Khairani, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
JAMA Cardiology|October 19, 2022
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical TrialParham Sadeghipour, Yaser Jenab, Jamal Moosavi, et al.
Thrombosis and Haemostasis|August 15, 2015
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer studyNick van Es, Marcello Di Nisio, Suzanne M Bleker, et al.
JAMA|October 5, 2021
Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical TrialDavid Jiménez, Alvar Agustí, Eva Tabernero, et al.
Thrombosis Research|June 1, 2023
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS studyRemedios Otero, José Luis Lobo, Raquel López, et al.
JAMA Cardiology|June 1, 2022
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A ReviewBehnood Bikdeli, Farbod Zahedi Tajrishi, Parham Sadeghipour, et al.
Pageof 39